Oryzon Genomics S.A. announced a private placement of 818,367 shares at an issue price of 2.2 per share for a gross proceeds of 800,407 on December 20, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 EUR | +0.92% | +0.51% | +4.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.34% | 121M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- ORY Stock
- News Oryzon Genomics S.A.
- Oryzon Genomics S.A. announced that it has received €1.800407 million in funding